Mucus Relief

Description

The product is a tablet identified by SPL code 34089-3. Each tablet contains active ingredient. The tablets are color and shape. Inactive ingredients include list of inactive ingredients. The product is packaged in packaging details.

Uses and Indications

This drug is indicated for the temporary symptomatic relief of congested chests and cough. It is intended for use in patients experiencing these symptoms, providing a short-term solution to alleviate discomfort associated with respiratory congestion.

Dosage and Administration

Adults and children 12 years of age and over are instructed to take one caplet daily. For children under 12 years of age, the use of this medication is not recommended. It is essential to adhere to the maximum dosage limit, which should not exceed four doses within a 24-hour period.

Contraindications

Use is contraindicated in patients who exceed the recommended dosage. Additionally, consumption of alcohol, benzodiazepines, or opioids is contraindicated due to potential interactions and increased risk of adverse effects.

Warnings and Precautions

A persistent cough may indicate an underlying serious condition. Healthcare professionals should advise patients to seek medical consultation if a cough persists for more than one week, recurs frequently, or is accompanied by additional symptoms such as fever, rash, or a persistent headache.

Prior to recommending use, it is essential to inquire about the patient's medical history. Patients with a persistent or chronic cough, particularly those associated with smoking, asthma, chronic bronchitis, or emphysema, should be advised to consult a healthcare provider. Additionally, if the cough is accompanied by excessive phlegm (mucus), medical advice should be sought before proceeding with treatment.

Patients should be instructed to discontinue use and consult a healthcare provider if the cough lasts longer than seven days. This precaution is critical to ensure that any potential underlying conditions are appropriately addressed.

In the event of an overdose, immediate medical assistance is required. Patients should be directed to contact a Poison Control Center at 1-800-222-1222 without delay.

Side Effects

Patients may experience a range of adverse reactions while using this product. A persistent cough may indicate a serious underlying condition; therefore, if the cough lasts for more than one week, recurs, or is accompanied by symptoms such as fever, rash, or persistent headache, patients are advised to consult a healthcare professional promptly.

It is crucial for patients to adhere to the recommended dosage and to avoid the consumption of alcohol, benzodiazepines, or opioids while using this product, as these substances may exacerbate adverse effects.

Patients should discontinue use and seek medical advice if their cough persists beyond seven days. Additionally, pregnant or breastfeeding individuals should consult a healthcare professional before using this product to ensure safety for both the mother and child.

To ensure safety, this product should be kept out of reach of children. In the event of an overdose, immediate medical assistance should be sought, or the Poison Control Center should be contacted at 1-800-222-1222.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Mucus Relief (guaifenesin 400 mg). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not use this medication. For adolescents aged 12 years and older, the recommended dosage is 1 tablet every 4 hours with a full glass of water, as needed while symptoms persist. It is important not to exceed 6 doses in a 24-hour period.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance. Healthcare professionals are advised to contact a Poison Control Center at 1-800-222-1222 for guidance on managing the situation effectively.

Prompt intervention is crucial, as the symptoms of an overdose may vary depending on the substance involved. Therefore, a thorough assessment of the patient's condition is necessary to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the specific symptoms presented by the patient. Continuous monitoring of vital signs and clinical status is essential to ensure patient safety and to address any complications that may arise during the management of an overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 in the event of an overdose. It is crucial for patients to understand the importance of adhering to the recommended dosage and to avoid exceeding it.

Patients should be informed that if their cough persists for more than 7 days, they must stop using the medication and consult their physician or healthcare provider for further evaluation. Additionally, healthcare providers should emphasize the risks associated with the concurrent use of alcohol, benzodiazepines, or opioids, and strongly advise patients against consuming these substances while using the medication.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at a controlled room temperature of 25°C (77°F), with permissible excursions between 15°C and 30°C (59°F and 86°F).

The product must be kept in a dry place, ensuring that it is not exposed to heat or moisture, which could compromise its integrity. Additionally, it is crucial to observe the tamper-evident feature; the product should not be used if the safety seal under the cap is broken or missing, as this indicates potential contamination or compromise of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Mucus Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)